tiprankstipranks
Cognition Therapeutics (CGTX)
NASDAQ:CGTX
US Market

Cognition Therapeutics (CGTX) Income Statement

Compare
283 Followers

Cognition Therapeutics Income Statement

Last quarter (Q3 2024), Cognition Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Cognition Therapeutics's net income was $-9.94M. See Cognition Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -252.00K$ -235.00K$ -93.00K$ -98.00K$ -81.00K
Operating Expenses
$ 50.72M$ 21.33M$ 11.15M$ 6.55M$ 4.67M
Depreciation and Amortization
$ 252.00K$ 235.00K$ 93.00K$ 98.00K$ 81.00K
EBITDA
$ -25.51M$ -21.13M$ -13.38M$ -5.99M$ -3.50M
Operating Income
$ -50.72M$ -43.55M$ -28.60M$ -17.41M$ -17.83M
Other Income/Expenses
$ 24.94M$ 22.15M$ 16.88M$ 9.57M$ 12.99M
Pretax Income
$ -25.79M$ -21.40M$ -11.72M$ -7.84M$ -4.84M
Net Income
$ -25.79M$ 757.00K$ -10.29M$ -10.07M$ -6.95M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.86$ 0.03$ -0.46$ -0.46$ -0.32
Diluted EPS
$ -0.86$ 0.03$ -0.46$ -0.46$ -0.32
Weighted Average Shares Outstanding
29.99M 28.99M 22.23M 21.94M 21.94M
Weighted Average Shares Outstanding (Diluted)
30.03M 28.99M 22.23M 21.94M 21.94M
Currency in USD

Cognition Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis